Towa Pharmaceutical Co., Ltd.
4553.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥45,471 | ¥29,650 | ¥24,257 | ¥32,830 |
| Short-Term Investments | ¥0 | ¥0 | ¥0 | ¥0 |
| Receivables | ¥71,631 | ¥71,657 | ¥54,392 | ¥50,748 |
| Inventory | ¥108,287 | ¥101,072 | ¥92,927 | ¥72,701 |
| Other Curr. Assets | ¥21,917 | ¥15,339 | ¥11,414 | ¥10,585 |
| Total Curr. Assets | ¥247,306 | ¥217,718 | ¥182,990 | ¥166,864 |
| Property Plant & Equip (Net) | ¥168,423 | ¥153,642 | ¥127,004 | ¥100,857 |
| Goodwill | ¥28,115 | ¥32,568 | ¥34,613 | ¥44,647 |
| Intangibles | ¥17,727 | ¥18,018 | ¥18,331 | ¥9,454 |
| Long-Term Investments | ¥1,377 | ¥1,248 | ¥3,104 | ¥3,035 |
| Tax Assets | ¥6,037 | ¥5,699 | ¥5,303 | ¥5,075 |
| Other NC Assets | ¥1,838 | ¥1,760 | -¥1 | -¥2 |
| Total NC Assets | ¥223,517 | ¥212,935 | ¥188,354 | ¥163,066 |
| Other Assets | ¥0 | ¥5 | ¥3 | ¥5 |
| Total Assets | ¥470,823 | ¥430,653 | ¥371,347 | ¥329,935 |
| Liabilities | – | – | – | – |
| Payables | ¥30,041 | ¥26,372 | ¥31,284 | ¥17,041 |
| Short-Term Debt | ¥25,488 | ¥13,232 | ¥11,204 | ¥61,507 |
| Tax Payable | ¥0 | ¥7,926 | ¥1,190 | ¥4,285 |
| Deferred Revenue | ¥0 | ¥7,926 | ¥14,129 | ¥15,644 |
| Other Curr. Liab. | ¥32,410 | ¥24,662 | ¥20,722 | ¥16,596 |
| Total Curr. Liab. | ¥87,939 | ¥80,118 | ¥78,529 | ¥115,073 |
| LT Debt | ¥206,878 | ¥189,124 | ¥150,314 | ¥79,194 |
| Deferred Rev, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Tax Liab, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Other NC Liab. | ¥4,378 | ¥5,519 | ¥5,611 | ¥5,662 |
| Total NC Liab. | ¥211,256 | ¥194,643 | ¥155,925 | ¥82,694 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥13,184 | ¥0 | ¥0 | ¥0 |
| Total Liabilities | ¥299,195 | ¥274,761 | ¥234,454 | ¥197,767 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥128,179 | ¥129,078 |
| Common Stock | ¥4,717 | ¥4,717 | ¥4,717 | ¥4,717 |
| Retained Earnings | ¥150,502 | ¥134,452 | ¥121,232 | ¥122,131 |
| AOCI | ¥14,149 | ¥14,491 | ¥8,714 | ¥3,090 |
| Other Equity | ¥2,257 | ¥2,232 | ¥2,229 | ¥2,229 |
| Total Equity | ¥171,625 | ¥155,892 | ¥136,893 | ¥132,168 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liab. & Tot. Equity | ¥470,823 | ¥430,653 | ¥371,347 | ¥329,935 |
| Net Debt | ¥186,895 | ¥172,706 | ¥137,261 | ¥107,871 |